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2Abstract
Human trophoblast differentiates into two pathways: extravillous cytotrophoblasts
(EVCT) that invade the uterus wall and villous cytotrophoblasts (VCT) that fuse to form the
syncytiotrophoblast (ST) involved in placental exchanges and endocrine function. It is
established that hCG is produced and secreted by the ST into the maternal compartment where it
plays a key endocrine role and stimulates ST formation in an autocrine manner. Herein, we
investigated hCG expression in early placentas by immunohistochemistry using different
antibodies. We then compared hCG secretion by primary cultures of VCT and EVCT isolated
from the same first trimester human chorionic villi. In situ hCG was immunodetected in EVCT
all along their invasive differentiating pathway excepted in cells near the stromal core of the
proximal column. hCG expression was confirmed in vitro by immunocytochemistry and hCG
secretion quantified in cell supernatants. Interestingly, whereas hCG secretion increased during
VCT differentiation into ST (from 60 to 350 UI/L/µg DNA), EVCT secretion remained constant
and at a high level during the same culture period (160 UI/L/µg DNA). Our data demonstrated
that in addition to the ST, invasive EVCT also expressed and secreted high levels of hCG,
suggesting a specific paracrine and/or autocrine role for hCG from EVCT origin.
3Introduction
After implantation, human trophoblasts follow two differentiation pathways: the villous
and the extravillous cytotrophoblasts that display different phenotypes and functions (cf. Fig.
2A). The mononucleated villous cytotrophoblasts (VCT) that cover the floating chorionic villi
aggregate and fuse to form a multinucleated syncytiotrophoblast (ST), which is involved in the
exchange of gases and nutrients between the mother and the fetus. Moreover, the ST represents
the endocrine tissue of the placenta, secreting large amounts, unparalleled in other mammals, of
protein hormones including human chorionic gonadotropin hormone (hCG) (1). The trophoblasts
located at the tip of the anchoring villi contacting the uterine wall follow a different
differentiation pathway. These trophoblasts, named extravillous cytotrophoblasts (EVCT),
proliferate to form multilayered columns of cells and then invade the decidua up to the upper
third of the myometrium. At the deciduo-muscular junction, EVCT undergo a final differentiation
into multinucleated giant cells. Trophoblastic infiltration of the arterial wall is accompanied by
dramatic structural changes of the vascular media such as the lost of elastic fibres and smooth
muscle cells which are usely attributed to proteolytic activities of the invasive endovascular cells
(2). Hence, EVCT are directly involved in the anchoring of chorionic villi in the uterus, and in
the essential remodeling of the uterine arterioles to provide adequate supply of maternal blood to
the intervillous space necessary for fetal growth (3-7).
Human chorionic gonadotropin hormone, specific to humans and great apes, is a
glycoprotein composed of an alpha subunit (α hCG), which is common to other peptide
hormones such as LH (luteinizing hormone), FSH (follicle stimulating hormone) and TSH
(thyroid stimulating hormone), and a beta subunit (β hCG), which confers the biological
specificity of the hormone (8, 9). α hCG is encoded by a single gene and β hCG by 6 genes of
which the CGß5 gene is expressed predominantly in the placenta (10, 11). After implantation,
hCG is the first trophoblast signal detected in the maternal blood and is used as a diagnostic
marker of pregnancy. hCG and its free β subunit are detected in the maternal blood from the
4second week of pregnancy with peak levels at twelve weeks and then gradually decrease; α hCG
levels increase progressively up to term (12). Maintenance of pregnancy during the first trimester
depends on the synthesis of hCG, which prevents regression of the corpus luteum (13) allowing
the maintenance of ovarian progesterone secretion (1). In addition to its well-established
endocrine role, hCG plays an autocrine/paracrine role in human trophoblast differentiation (14,
15).
Although the synthesis and secretion of hCG by the villous trophoblast is well established
and documented (16), presence of hCG in the cytotrophoblast from extravillous origin remains
controversial since opposite results were reported by different authors (17-19). Therefore, in the
present study we first investigated in situ the localization of hCG at the feto-maternal interface
using different antibodies. Then, we examined the in vitro expression and secretion of hCG in
cultured villous and extravillous cytotrophoblasts isolated from the same chorionic villi of first
trimester human placentas, and compared quantitatively the hCG secretion of each
cytotrophoblastic cell type.
5Materials and Methods
Materials
Placental tissues from patients who voluntarily and legally chose to terminate pregnancy
during the first trimester (8-12 wk of gestation) were obtained from Broussais Hospital (Paris,
France, n=14). All patients gave informed consent. We also obtained paraffin sections of an
implantation site (placenta and myometrium) at 16 wk of gestation from the pathology
department of “La Citadelle Hospital” (Liège, Belgium). Hysterectomy was performed because
of cervical carcinoma stage IIa diagnosed at 15 wk.
Immunohistochemistry
Samples from 8-12 wk placentas were either fixed by incubation in 4% formalin for 4 to
24 h at room temperature and then embedded in paraffin (n=3), or embedded in TissueTek,
frozen in isopentan and kept at -80°C until use (n=4). Paraffin sections of the 8-12 wk placentas
and of the 16 wk of gestation implantation site (placenta and myometrium obtained from
Belgium) were dewaxed in xylene and rehydrated in ethanol/water. Sections were then incubated
for 45 min in citrate buffer at 90°C for antigen retrieving. Immunostaining was performed with a
streptavidin-peroxidase immunostaining kit (Peroxidase, Dako, LSAB® + Kit DAKO©, Trappes,
France). Samples were permeabilized for 4 min in 0.3 % Triton X-100 (for cytokeratin 7 (CK7)
and Ki67 immunodetections only) and non-specific binding was blocked by incubation for 5 min
in a blocking reagent containing 3% H2O2 and then in 3 % serum albumin in PBS buffer for 30
min. The sections were incubated with several antibodies directed against different hCG epitops,
with an anti-Ki67 antibody and with an anti-CK07 antibody for 30 min at room temperature.
Characteristics for each antibody are detailed in Table 1. Sections were washed in PBS
and incubated with a biotinylated secondary antibody for 15 min. They were then washed 3 times
in PBS and incubated with streptavidin conjugated to horse-radish peroxidase for 15 min. The
sections were washed in PBS and staining was detected by incubation for 2 min with the DAB
(3,3’-diaminobenzidine) chromogen. Controls were performed by incubating the sections with
6nonspecific IgG at the same concentration as the primary antibody. Preparations were
counterstained with hematoxylin blue (except for Ki67 staining) and mounted in an aqueous
mounting medium (Aqueous Mounting Medium, DAKO©, Trappes, France), then examined and
photographed with an Olympus BX60 microscope.
Isolation and Purification of villous (VCT) and extravillous (EVCT) cytotrophoblasts
Seven different isolations of EVCT and VCT were performed using seven independent
human chorionic villi from first trimester legally induced abortion. EVCT and VCT were each
time isolated from the same chorionic villi by differential trypsin digestion according to the
methods of Tarrade et al (20) with slight modifications. Chorionic villi were washed, dissected
and rinsed in Ca2+, Mg2+-free HBSS supplemented with 100 UI/mL penicillin and 100 µg/mL
streptomycin.
For EVCT isolation, the tissue was incubated in HBSS (5 mL/g) containing 0.125%
trypsin (Difco Laboratories, Detroit, Michigan), 4.2 mM MgSO4, 25 mM Hepes, 50 U/mL Dnase
type IV (Sigma, Saint-Quentin Fallavier, France) for 35 min at 37°C without agitation. After
tissue sedimentation, the supernatant containing isolated EVCT was filtered (100 µm) and stored
in the presence of 10% (v/v) fetal calf serum (FCS) to inhibit trypsin activity. The tissue was
washed five to six times with warm HBSS and supernatant fractions were pooled. Cells were
centrifuged at 300 X g for 10 min, washed twice in HBSS supplemented with 10% FCS and
filtered on a 50 µm pore nylon membrane. The cell suspension was carefully layered over a
discontinuous Percoll gradient and centrifuged for 25 min at 1000 X g. The layer corresponding
to 40-45% Percoll containing cytotrophoblasts was washed twice in HBSS supplemented with
10% FCS. Cells were diluted to a concentration of 2.5 x 105 cells/mL in HAM-F12/DMEM (v/v)
supplemented with 10% FCS, 2 mM glutamine, 100 UI/mL penicillin and 100 µg/mL
streptomycin and plated at a density of 50 000 cells per cm2 on Matrigel-coated (5 mg/mL; BD
Biosciences, Le Pont-de-Claix, France) 35-mm Falcon culture dishes. After 2 h of culture in 5%
CO2 at 37°C, cells were carefully washed three times to eliminate nonadherent cells. Each
7preparation of purified EVCT was characterized using immunocytochemistry and real-time PCR
and 97 % of cells were shown to express in vitro the specific markers of human invasive EVCT
in situ as described previously i.e., cytokeratin 7, human leukocyte antigen G (HLA-G), CD9,
human placental lactogen, c-erbB2 and α5β1 and were negative to vimentin (20, 21) and as
recently published (22). These purified EVCT were non proliferative and highly invasive on
Matrigel-coated transwells or dishes (23).
VCT isolation is based on the protocol of Kliman et al (16) and is a modified version of
the Tarrade et al protocol (20). After EVCT isolation, the same chorionic villi were incubated for
30 min at 37°C without agitation in 5 mL/g of tissue of the digestion buffer described above but
containing only 0.0625% trypsin. The first 30 min trypsin digestion, containing a mix of EVCT
and VCT, was discarded. The chorionic villi were then incubated in the same trypsin solution for
30 min and twice for 15 min at 37°C without agitation, and finally washed with warm HBSS.
Each time, the supernatant containing VCT was collected after tissue sedimentation, filtered (100
µm), and incubated on ice with 10% FCS (v/v) to stop trypsin activity. After Percoll gradient
fractionation, cells were diluted to a concentration of 1.25 x 106 cells/mL in DMEM
supplemented with 10% FCS, 2 mM glutamine, 100 UI/mL penicillin and 100 µg/mL
streptomycin and plated at a density of 150 000 cells per cm2 on 35-mm or 60-mm TPP (Techno
Plastic Products) tissue culture dishes. VCT were incubated overnight in 5% CO2 at 37°C and
washed three times to eliminate non-adherent cells. Purified VCT cultures were characterized by
positive staining for CK7 (95% positive cells) and by the observation of cell aggregates and
syntytiotrophoblasts from 48 to 72 h.
hCG Immunocytochemistry
hCG simple labelling
EVCT and VCT were fixed for 20 min in 4% paraformaldehyde after 24 to 72 h of
primary culture. Cells were rinsed three times with PBS and immunostained for hCG (HT13
antibody, see Table 1) using a streptavidin-peroxidase immunostaining kit (Peroxidase, Dako,
8LSAB® + Kit, DAKO©, Trappes, France) as described for immunohistochemistry.
hCG / Ki67 double labelling
EVCT were fixed for 20 min in 4% paraformaldehyde after 2 and 48 h of primary culture
on Matrigel. Cells were rinsed three times with PBS and permeabilized 4 min in Triton 0.3%.
Saturation of unspecific sites was performed in 7% donkey and goat serum diluted in PBS for 1 h
at room temperature. Primary antibodies (monoclonal mouse anti-Ki67, 1/100 and polyclonal
rabbit anti-hCG A0231, 1/1000, DAKO, France) diluted in PBS containing 1% BSA were added
for 2 h at room temperature and amplified with the secondary antibody (CY3-conjugated donkey
anti-mouse IgG1 and FITC-conjugated goat anti-rabbit IgG, 1/300, Jackson Immunoresearch
Laboratories, West Groove, PA) diluted in PBS for 1 h in dark at room temperature. Cells were
mounted in a fluorescent Dapi mounting medium, examined and photographed on an Olympus
BX60 epifluorescence microscope.
Controls were performed by incubating the cells with a non specific IgG at the same
concentration as the primary antibody.
Immunoblotting
Four couples of ST and EVCT isolated from the same chorionic villi were analysed. Each
culture medium was separated by 4-12% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis in pH 7 running buffer. After transfer, detection was enhanced by the QuentixTM
Western Blot Signal Enhancer Kit (Pierce, Rockford IL, USA). On blots, hCG was detected with
A0231 antibody (1/500) itself detected using horseradish peroxidase-conjugated sheep anti-rabbit
IgG antibodies (1/40000) and enhanced chemiluminescence reagents (Pierce, Rockford IL, USA).
Hormone assays
Total hCG was determined using the chemiluminescent immunoassay analyzer ACS-
9180SE system (Bayer Diagnostics, Westwood CA, USA). The assay used for total hCG
quantification was a sandwich immunoassay that recognized free β -subunit, nicked and intact
hCG. Two antibodies were used: a capture mouse monoclonal anti-hCG antibody and a labelled
polyclonal goat anti-hCG antibody, which were raised against two different epitopes of the β -
subunit of hCG. Performance characteristics were as follows: range 2-1000 UI/L; within-run
precision 2.8% and between-run precision 5.6%; functional detection limit 1 UI/L. Samples were
diluted (1/100) in the reaction buffer when necessary. In order to compare the secretion of hCG in
VCT and EVCT supernatants, results were normalized to one µg of DNA.
DNA quantification
Cell pellets were solubilized in 5 M GuSCN, 0.1 M EDTA, pH 7 and stored at –80°C until
use. DNA was quantified by fluorometry using the fluorochrome Hœchst 33258 as described by
Labarca and Paigen (24).
Statistical analysis
Values represent the mean ± SEM of 3 separate cultures obtained from different
placentas. The Mann and Whitney (*) test was used to compare EVCT vs VCT. The Kruskal and
Wallis test ($) was used to compare protein secretion from 24-, 48- and 72-h VCT cultures.
Results were considered significant when P < 0.05.
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RESULTS
In situ immunodetection of hCG at the implantation site
To date, the presence of hCG in EVCT along their differentiating and invasive pathway
remains controversial. Therefore, we first examined the expression of hCG in human placentas
from 8 to 16 wk of gestation by immunohistochemistry. Placental portions were either embedded
in TissueTek and frozen or fixed with formalin for 4 h or for 12 to 24 h. Three anti-hCG
antibodies were used in the present study (Table 1): the HT13 monoclonal antibody raised against
the α-subunit of hCG; the FB12 monoclonal and the A0231 polyclonal antibodies both raised
against the ß-subunit of hCG. These three antibodies recognized both the free subunit (α or ß)
and total hCG.
Results are summarized in Table 2. Irrespective of the fixation and antibodies used, the
profound myometrium remained negative for hCG immunostaining. VCT and ST known to
express hCG were labelled in all conditions except with the FB12 antibody after a 4-h formalin
fixation. In EVCT a positive labelling was found using the polyclonal A0231 antibodies in all
conditions. Using the FB12 antibody, hCG was immunodetected in EVCT only on frozen section
whereas the HT13 antibody detected hCG in EVCT on paraffined sections after a short formalin
fixation time (4 h).
Figure 1 depicts a representative immunohistochemistry experiment obtained after
fixation of the 16 wk-placenta sections for 4 h in formalin and immunostained for hCG (Fig. 1A:
A0231 antibody, Fig. 1B: HT13 antibody), for Ki67 (Fig. 1C) and with isotypic IgG used as
control (Fig. 1D). Zoom of different sites from sections immunostained with the HT13 antibody
are presented in Fig 2. As shown in Figure 1 and 2, syncytiotrophoblast, villous and extravillous
cytotrophoblasts were stained positively with HT13 and A0231 antibodies. As shown in Fig. 1
A&B and in Fig. 2 C, E, & F all types of EVCT along their differentiating pathway stained
positive for hCG, i.e. EVCT from the column (zoom in Fig. 2E), invasive EVCT (zoom in Fig.
2F), endovascular EVCT (zoom in Fig. 2F) and giant multinucleated cells (zoom in Fig. 2C). A
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few cytokeratin 7 negative cells in the stromal core stained positive for hCG (Fig. 1A&B),
whereas profound myometrium remained negative (Fig. 2D).
We noticed that in the proximal column from first and second trimester placenta sections,
most of the EVCT located at the tip of the villi close to the stromal core were not immunostained
for hCG and were positive for Ki67 (Fig. 1A-C and Fig.3 A&B). EVCT distant from the stromal
core became positive for hCG (Fig. 1A, B, Fig.2E and Fig.3 A) and most of the EVCT from the
distal column were immunostained (Fig. 1A, B and Fig. 2E). Most of these cells were still
positive for Ki67 (Fig. 1C and Fig.3B). Finally, invasive EVCT in the decidua and endovascular
EVCT were all positive for hCG (Fig. 1A&B, Fig 2E&F) and negative for Ki67 (Fig. 1C).
We next examined the phenotype of extravillous cells isolated from first trimester
chorionic villi and cultured on Matrigel (Fig. 3C-F). We observed that at 2 h of culture (Fig
3C&D) 65% of EVCT were positive for Ki67, 30% were positive for hCG and 15% were hCG /
Ki67 double positive. At 48 h (Fig. 3E&F), most of the invasive EVCT (93%) were exclusively
hCG positive and only 7% of EVCT were double positive.
Comparative expression of hCG in human VCT and EVCT primary cultures
We investigated the in vitro expression of hCG in cultures of villous and extravillous
cytotrophoblasts isolated from first trimester chorionic villi. Figures 4A&B show
immunodetection of hCG in cultured-VCT and EVCT. Mononucleated VCT in culture adhered to
plastic dishes, aggregated at 48 h and fused to form a multinucleated syncytiotrophoblast at 72 h
(Fig. 4A). EVCT require extracellular matrix-coated dishes for adhesion and culture, they display
an invasive phenotype and emitt pseudopodia (20). Using HT13 (Fig. 4A&B) and A0231 (data
not shown) antibodies, hCG was immunodetected in VCT at all stages of their differentiating
pathway into ST (Fig. 4A) and in invasive EVCT at each time point (Fig. 4B). No staining was
obtained neither in VCT nor in EVCT using isotypic IgG1 (Fig. 4A&B, left panels).
We next analysed hCG secretion in culture media by immunoblotting. As shown in Fig.
4C, we detected hCG and its free β-subunit with A0231 antibody with a molecular apparent
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weight of 38 kD and of 25 kD, respectively.
We finally quantified and compared the secretion of total hCG in VCT and EVCT culture
supernatants after normalization to DNA content. As shown in Figure 4D and now well
established, VCT secreted increasing amount of total hCG along their differentiation into ST. In
contrast, EVCT showed a stable production of total hCG along the 72 h culture period. At 24 h,
EVCT secreted two-fold more total hCG than mononucleated VCT (P < 0.001). At 48 h, total
hCG secretion was identical in EVCT and aggregated VCT. As expected, the multinucleated ST
at 72 h was the most potent hCG producer of total hCG (P < 0.01).
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DISCUSSION
In this study, we established that cytotrophoblasts from extravillous origin expressed the
human chorionic gonadotropin hormone in situ all along their invasive pathway. These data were
confirmed in vitro using invasive EVCT primary cultures obtained from first trimester human
placentas. Indeed, in contrast with the well-established in vivo (25) and in vitro hCG expression
in villous trophoblast (16, 26, 27), the presence of hCG in EVCT has been investigated only by
immunohistochemistry and results remained controversial. Although Gosseye and Fox have
never detected this hormone in EVCT irrespective of the term studied (19), other authors have
shown positive staining in different sub-types of EVCT. Results from Sasagawa et al, showed
that the α - and β-subunits of hCG were restricted to the mononuclear trophoblast in the
superficial decidua of first and second trimester placentas (17), whereas results from Kurman et
al, showed that hCG was exclusively expressed by giant multinucleated cells in term placentas
(18).
In the present study, using several antibodies (monoclonal and polyclonal) raised against
different hCG epitopes, we showed that almost all sub-types of EVCT from 8 to 16 wk placental
sections expressed hCG: cells from the column, invasive, endovascular and giant multinucleated
cells. However, we noticed that a few EVCT from the proximal column in contact with the
stromal core were negative for hCG staining. Most of the EVCT in the column were positive for
Ki67, whereas invasive EVCT in the decidua were all negative. This suggests that during their
differentiating pathway from proliferating cells in the column to invasive cells in the decidua,
EVCT exit cell cycle and express hCG. Since induction and inhibition of gene expression are
dynamic processes, EVCT co-expressing hCG and Ki67 were observed in situ as well as in vitro.
Our results suggest that hCG could be a marker of invasive extravillous cytotrophoblasts
and might potentially play a role in trophoblast invasion as it has been proposed recently by assay
on immortalized EVCT (28). The reason why we obtained different results than others is
probably linked to the technical process. Because immunostaining is dependent of multiple
factors such as the fixation step that determines the antigen structure and therefore the antibody
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specificity, in the present study we used both frozen and paraffin-fixed sections using various
fixation times and three different antibodies. We showed in Table 2 that results differed
dramatically depending on the antibody and tissue process. However, for each antibody we found
the best compromise allowing the detection of hCG in both EVCT and VCT/ST from the same
placental section, VCT and ST being considered as a positive control for the presence of hCG.
We also found hCG positive cells in the mesenchymal stroma of chorionic villi, which probably
correspond to macrophages called Hofbauer cells. Localization of hCG in human Hofbauer cells
has been reported by others. They provided evidence that these macrophages ingest hCG secreted
by the ST and play a role in degradation and production of nicked hCG (29).
We next studied the expression of hCG in vitro in a population of purified EVCT and
VCT considered to be the main source of hCG. In the present study, human extravillous and
villous cytotrophoblasts were isolated and purified from the same first trimester chorionic villi.
They were characterized by immunocytochemistry using different antibodies according to the
established differentiation markers specific for these two trophoblast lineages (20, 21, 30, 31). As
previously described (20), these two trophoblast types have different behavior in culture. VCT
adhere to plastic dishes, aggregate and fuse to form a syncytiotrophoblast. EVCT need an
extracellular matrix for adhesion and culture, digest and invade this matrix. We previously
showed that primary EVCT cultured on Matrigel are non proliferative cells (23) that acquire and
display an invasive phenotype in vitro after a few hours of culture, as described by expression of
specific markers and the ability to invade extracellular matrix in Boyden chambers (20, 32).
Using these in vitro models, we confirmed by immunocytochemistry the presence of hCG in
invasive EVCT. Using different methods of detection (hormonal assays and immunoblotting), we
showed that, unexpectedly, EVCT produced high levels of hCG compared to cytotrophoblast of
villous origin (intermediate between mononucleated VCT and ST). Furthermore, we found that
the capacity of primary invasive EVCT to secrete hCG remained constant from 24 to 72 h of
culture, whereas the secretory capacity of villous trophoblast increased during their
differentiation into a ST as previously reported in cultures from early and term placentas (16, 27).
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This discrepancy is probably due to the fact that EVCT displayed the same invasive phenotype
during the three-day study in contrast with VCT, which differentiate into ST.
An important role of hCG at the feto-maternal interface has been reported by different
investigators (33, 34). LH/CG receptors have been described in EVCT (35) and in vascular
endothelial cells (36). Our study strongly suggests that hCG secreted by invasive EVCT might act
as autocrine and/or paracrine factor for EVCT differentiation and/or endothelial cells from the
uterine arteries. Indeed, the regulatory effect of hCG in the invasion of the choriocarcinoma JEG-
3 (36) or of immortalized EVCT (28) have been reported and recent studies proposed hCG as a
novel angiogenic factor (38). Further studies should increase the level of understanding as to the
role of hCG produced by extravillous cytotrophoblast and its implication in trophoblast invasion
and vascular remodeling.
In conclusion, this study used severals methods and antibodies to demonstrate that
invasive extravillous cytotrophoblasts are a significant source of hCG that might play a role at the
feto-maternal interface.
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Figure legends
Fig. 1: Immunodetection of hCG at the human implantation site.
16 wk-placenta paraffined serial sections were fixed for 4 h and immunostained for hCG using
the A0231 antibody (A) and the HT13 antibody (B). Ki67 immunostaining was performed to
detect proliferative cells (C), and isotypic IgG1 was used as control (D). Magnificance : x 400
p: proximal column; i: invasive evct; e: endovascular evct; usa: uterine spiral artery (panel A).
Fig. 2: Immunodetection of hCG in extravillous cytotrophoblast.
A , Scheme of an anchoring villus. sc: stromal core; vct: villous cytotrophoblast; st:
syncytiotrophoblast; fv: floating villi; is: intervillous space; av: anchoring villi; evct: extravillous
cytotrophoblast; p: proliferative evct; i: invasive evct; e: endovascular evct; gc: giant cells; d:
decidual cells; usa: uterine spiral artery. Panels B to F depict hCG immunodetection using the
HT13 antibody: B . a section of floating villi; C. a giant cell; D . a section of profound
myometrium; E , proximal and distal column of EVCT with invasive EVCT; F, a uterine
remodelled artery invaded by endovascular EVCT. Bar: 20 µm. Panel G is a large section
showing CK7 positive EVCT and the uterine artery of panel F.
Fig. 3: Immunodetection of hCG and Ki67 in extravillous cytotrophoblast in situ and in vitro.
Panels A&B are serial sections of a paraffined first trimester anchoring villi. A. Immunodetection
of hCG with HT13 antibody.  B. Immunodetection of Ki67. Bar: 20 µm; sc: stromal core.
C. Immunodetection of hCG (A0231 antibody) and Ki67 in EVCT isolated from first trimester
chorionic villi and cultured for 2h on Matrigel (D. isotype-matched control). E. Immunodetection
of hCG (A0231 antibody) and Ki67 in 48h-cultured EVCT (F. isotype-matched control). Bar: 50
µm.
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Fig. 4: Detection of hCG in human cultured villous and extravillous cytotrophoblasts.
A. Villous cytotrophoblasts in culture differentiated from a mononuclear cell to a syncytium over
72 h. B. Extravillous cytotrophoblasts in culture on Matrigel displayed an invasive phenotype,
emitted pseudopodia and formed a network as shown at 48 h. Cells were immunostained for hCG
using the HT13 antibody and IgG1 was used as an isotypic control. Scale bar: 20 µm. C.
Detection of hCG in ST and EVCT culture medium by immunoblotting using A0231 antibody.
D. Comparative secretion of hCG by human VCT and EVCT in culture. Supernatants from 24,
48, and 72 h-cultured VCT and EVCT were collected and total hCG was measured as described
in Materials and Methods. Protein secretions were expressed as UI/L and normalized to DNA
content for comparison between VCT and EVCT. Values represent the mean ± SEM of three
independent cultures isolated from three different placentas. Mann and Whitney test was used to
compare EVCT vs VCT (** P<0.01 and *** P<0.001). Kruskal and Wallis test was used to
compare VCT hCG secretions at 24, 48 and 72 h of culture ($ P<0.0001).
